These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22705702)

  • 1. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Ishida M; Miyazawa T; Ebe K; Koide N; Fujita N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2013 Jan; 40(1):103-5. PubMed ID: 23306929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
    Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
    Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
    Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].
    Suzuki S; Shigaki N; Yokoyama S; Yamashita H; Sugita H; Arima N
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1545-7. PubMed ID: 21918360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of locally advanced rectal cancer had a pathological complete response to XELOX Therapy].
    Tonoike Y; Kawahara M; Makino S; Nishimura A; Kawachi Y; Nikkuni K; Sato A; Fukuhara Y; Watanabe S; Sato T; Tomidokoro T; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):683-6. PubMed ID: 22504703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of advanced rectal cancer resected successfully after preoperative XELOX chemotherapy].
    Yagi Y; Iiai T; Saitou K; Kameyama H; Nogami H; Umezu H; Hatakeyama K
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1221-4. PubMed ID: 21772117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].
    Uehara M; Sakamoto K; Konishi S; Hamasu S; Nishitai R; Manaka D
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1541-3. PubMed ID: 21918359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].
    Murata K; Okamura S; Okubo H; Owada Y; Nishigaki T; Wada Y; Kato R; Makino S; Takeoka T; Okada K; Fukuchi N; Ebisui C; Kinuta M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2020-2. PubMed ID: 24393999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer.
    Uehara K; Ishiguro S; Sakamoto E; Maeda A; Inoue M; Tojima Y; Kobayashi S; Omiya N; Ishizuka N; Nakao A; Goto H; Nagino M
    Jpn J Clin Oncol; 2011 Aug; 41(8):1041-4. PubMed ID: 21803876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of necrotizing fasciitis developed in a patient with recurrent rectal cancer treated with chemotherapy].
    Shimada A; Nakamura T; Ishii M; Chiba N; Ishikawa S; Arisawa Y; Hashimoto M
    Gan To Kagaku Ryoho; 2013 May; 40(5):663-5. PubMed ID: 23863596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of bevacizumab-based preoperative radiochemotherapy in patients with locally advanced rectal cancer on surgery-associated spectrum of complications.
    Dellas K; Buller J; Görtz GJ; Richter M; Höhler T; Arnold D; Keck T; Dunst J; Zühlke H
    Ann Surg Oncol; 2014 Apr; 21(4):1352-60. PubMed ID: 24306667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.
    Ueki T; Manabe T; Inoue S; Ienaga J; Yamanaka N; Egami T; Ishikawa M; Konomi H; Ikubo A; Nagayoshi K; Nakamura M; Tanaka M
    Anticancer Res; 2016 Feb; 36(2):741-7. PubMed ID: 26851033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial.
    Xiao J; Chen Z; Li W; Yang Z; Huang Y; Zheng J; Deng Y; Wang L; Ren D; Peng J; Lan P; Wang J
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):21-7. PubMed ID: 25952796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete response obtained by preoperative chemotherapy in a case of T4 rectal cancer].
    Yokoyama H; Akasaka H; Morohashi H; Sakamoto Y; Koyama M; Murata A; Hakamada K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1954-6. PubMed ID: 23267941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
    Sueda T; Noura S; Ohue M; Shingai T; Gotoh K; Motoori M; Takahashi H; Kishi K; Marubashi S; Fujiwara Y; Ohigashi H; Yano M; Tomita Y; Ishikawa O
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1965-7. PubMed ID: 24393981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
    Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
    Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.